Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
Nephros Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
4,10 9,04 0,34 34 983
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiNephros Inc
TickerNEPH
Kmenové akcie:Ordinary Shares
RICNEPH.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 31
Akcie v oběhu k 03.11.2025 10 626 683
MěnaUSD
Kontaktní informace
Ulice380 Lackawanna Pl
MěstoSOUTH ORANGE
PSČ07079-1704
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon12 013 435 202
Fax12013435207

Business Summary: Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Nephros Inc revenues increased 37% to $14.1M. Net income totaled $1.1M vs. loss of $275K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Water solutions segment income totaling $562K vs. loss of $311K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.03 to $0.11.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Purification & Treatment Equipment
RBSS2004Advanced Medical Equipment
MGINDUSTRYMisc. Capital Goods
MGSECTORCapital Goods
NAICSCommercial and Service Industry Machinery Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Oth Commercial/Service Industry Machinery Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS1997Other Commercial and Service Industry Machinery Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICService Industry MacHinery, Nec
SICElectromedical Equipment
SICWater Supply
SICProcess Control Instruments



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorRobert Banks5011.05.202311.05.2023
Chief Financial OfficerJudith Krandel6001.11.202301.11.2023